Literature DB >> 24535568

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library.

Hiroko Koike-Yusa1, Yilong Li1, E-Pien Tan2, Martin Del Castillo Velasco-Herrera2, Kosuke Yusa2.   

Abstract

Identification of genes influencing a phenotype of interest is frequently achieved through genetic screening by RNA interference (RNAi) or knockouts. However, RNAi may only achieve partial depletion of gene activity, and knockout-based screens are difficult in diploid mammalian cells. Here we took advantage of the efficiency and high throughput of genome editing based on type II, clustered, regularly interspaced, short palindromic repeats (CRISPR)-CRISPR-associated (Cas) systems to introduce genome-wide targeted mutations in mouse embryonic stem cells (ESCs). We designed 87,897 guide RNAs (gRNAs) targeting 19,150 mouse protein-coding genes and used a lentiviral vector to express these gRNAs in ESCs that constitutively express Cas9. Screening the resulting ESC mutant libraries for resistance to either Clostridium septicum alpha-toxin or 6-thioguanine identified 27 known and 4 previously unknown genes implicated in these phenotypes. Our results demonstrate the potential for efficient loss-of-function screening using the CRISPR-Cas9 system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24535568     DOI: 10.1038/nbt.2800

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  46 in total

1.  Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.

Authors:  T Tsuzuki; Y Fujii; K Sakumi; Y Tominaga; K Nakao; M Sekiguchi; A Matsushiro; Y Yoshimura
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations.

Authors:  A Abuin; H Zhang; A Bradley
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

4.  The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

Authors:  R Hakem; J L de la Pompa; C Sirard; R Mo; M Woo; A Hakem; A Wakeham; J Potter; A Reitmair; F Billia; E Firpo; C C Hui; J Roberts; J Rossant; T W Mak
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

5.  A piggyBac transposon-based genome-wide library of insertionally mutated Blm-deficient murine ES cells.

Authors:  Wei Wang; Allan Bradley; Yue Huang
Journal:  Genome Res       Date:  2009-02-20       Impact factor: 9.043

6.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

Review 7.  Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress.

Authors:  Taroh Kinoshita; Morihisa Fujita; Yusuke Maeda
Journal:  J Biochem       Date:  2008-07-17       Impact factor: 3.387

8.  One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

Authors:  Haoyi Wang; Hui Yang; Chikdu S Shivalila; Meelad M Dawlaty; Albert W Cheng; Feng Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2013-05-02       Impact factor: 41.582

9.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

10.  Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon.

Authors:  Kosuke Yusa; Roland Rad; Junji Takeda; Allan Bradley
Journal:  Nat Methods       Date:  2009-03-31       Impact factor: 28.547

View more
  457 in total

Review 1.  Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.

Authors:  Vikram Pattanayak; John P Guilinger; David R Liu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  From hacking the human genome to editing organs.

Authors:  Takamasa Tobita; Jorge Guzman-Lepe; Alexandra Collin de l'Hortet
Journal:  Organogenesis       Date:  2015-11-20       Impact factor: 2.500

3.  Identification and characterization of essential genes in the human genome.

Authors:  Tim Wang; Kıvanç Birsoy; Nicholas W Hughes; Kevin M Krupczak; Yorick Post; Jenny J Wei; Eric S Lander; David M Sabatini
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

4.  A metric and workflow for quality control in the analysis of heterogeneity in phenotypic profiles and screens.

Authors:  Albert Gough; Tong Ying Shun; D Lansing Taylor; Mark Schurdak
Journal:  Methods       Date:  2015-11-04       Impact factor: 3.608

Review 5.  Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing.

Authors:  Manuel Kaulich; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2015-11-05       Impact factor: 5.486

6.  Massively parallel high-order combinatorial genetics in human cells.

Authors:  Alan S L Wong; Gigi C G Choi; Allen A Cheng; Oliver Purcell; Timothy K Lu
Journal:  Nat Biotechnol       Date:  2015-08-17       Impact factor: 54.908

Review 7.  Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors:  Mehmet Fatih Bolukbasi; Ankit Gupta; Scot A Wolfe
Journal:  Nat Methods       Date:  2016-01       Impact factor: 28.547

8.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

9.  Mapping regulatory elements.

Authors:  Yuexin Zhou; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2016-02       Impact factor: 54.908

Review 10.  CRISPR-Cas systems for editing, regulating and targeting genomes.

Authors:  Jeffry D Sander; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-03-02       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.